Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study
about
Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2018
@uk
name
Design and rationale of a rand ...... ysis: the AXADIA-AFNET 8 study
@en
Design and rationale of a rand ...... ysis: the AXADIA-AFNET 8 study
@nl
type
label
Design and rationale of a rand ...... ysis: the AXADIA-AFNET 8 study
@en
Design and rationale of a rand ...... ysis: the AXADIA-AFNET 8 study
@nl
prefLabel
Design and rationale of a rand ...... ysis: the AXADIA-AFNET 8 study
@en
Design and rationale of a rand ...... ysis: the AXADIA-AFNET 8 study
@nl
P2093
P2860
P1433
P1476
Design and rationale of a rand ...... ysis: the AXADIA-AFNET 8 study
@en
P2093
Christiane Engelbertz
Christoph Wanner
Holger Reinecke
Joachim Gerss
Rupert Bauersachs
Sabine Jürgensmeyer
P2860
P304
P356
10.1136/BMJOPEN-2018-022690
P407
P577
2018-09-10T00:00:00Z